SCHEMBL29396765

SCHEMBL29396765

C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CAPN1 P07384 7/20 0.52
▸ CTSB P07858 2/20 0.52
▸ GRB2 P62993 1/20 0.49
▸ XIAP P98170 1/20 0.48
▸ OPRM1 P35372 3/20 0.43
▸ SLC6A2 P23975 1/20 0.42
▸ OPRD1 P41143 1/20 0.42
▸ DPP4 P27487 3/20 0.41
▸ FAP Q12884 2/20 0.41
▸ DPP7 Q9UHL4 2/20 0.41
▸ PREP P48147 1/20 0.41
▸ DPP8 Q6V1X1 1/20 0.41
▸ DPP9 Q86TI2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30455247 1.00 CAPN1 (0.52) CAPN1CTSBGRB2XIAPOPRM1
SCHEMBL30069148 0.95 XIAP (0.52) CAPN1CTSBGRB2XIAPOPRM1
SCHEMBL19492652 0.91 CAPN1 (0.62) CAPN1CTSBGRB2XIAPOPRM1
SCHEMBL29576210 0.90 CAPN1 (0.55) CAPN1CTSBGRB2XIAPOPRM1
SCHEMBL29776901 0.89 GRB2 (0.53) CAPN1CTSBGRB2XIAPOPRM1
SCHEMBL29641846 0.88 GRB2 (0.51) CAPN1CTSBGRB2XIAPSLC6A2
SCHEMBL32689777 0.86 CAPN1 (0.57) CAPN1CTSBGRB2XIAPOPRM1
SCHEMBL29394895 0.86 CAPN1 (0.49) CAPN1CTSBGRB2XIAPOPRM1
SCHEMBL29468902 0.85 GRB2 (0.47) CAPN1CTSBGRB2XIAPOPRM1
SCHEMBL11090289 0.84 KMT2A (0.53) CAPN1CTSBXIAPSLC6A2DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4196495-A1 EXENDIN-4 PEPTIDE ANALOGUES TXP Pharma GmbH (CH) 2023-06-21 — — EP disclosed
EP-4144362-A1 COMPOSITIONS COMPRISING SHORT-ACTING HORMONES FOR TREATING OR PREVENTING OBESITY AND PUMPS COMPRISING SAID COMPOSITION Adocia (FR) 2023-03-08 — — EP disclosed
WO-2022034062-A1 EXENDIN-4 PEPTIDE ANALOGUES TXP PHARMA AG (CH) 2022-02-17 — — WO disclosed
Send feedback